DOI: 10.14264/uql.2015.292
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity of ascorbate to cancer cells: mathematical modelling, mechanisms and clinical implications

Abstract: Studies over the last few decades provided supportive evidence for further research on the use of intravenous administration of high-dose ascorbate (0.5 -1.5 grams per kilogram of body weight) in cancer treatment. Although intravenous ascorbate showed limited anticancer activity in the recent clinical trials, its potential beneficial effects were noted, such as improvement in quality of life, reduction of chemotherapy-associated toxicity, reduction of inflammation and stabilization of cancer progression. These… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 155 publications
(256 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?